Catalyst Edge · Scanner · Tickers · BNTX
CATALYST DOSSIER · UPDATED 2026-11-03

$BNTX

biotech · convergence 1 · conviction WATCH
Convergence Score
1
Conviction
WATCH
Signals Firing
4
Track Record
10/16
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $BNTX?

BNTX 1 WATCH biotech

Quantitative

  • Forward EPS estimate: $$0.85 (vs $($0.14) last yr YoY)
  • Market cap: $22,148,689,900
  • Convergence score: 1 (4 signals firing YoY)

Catalysts

  • Clinical trial milestone: A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembroli

Risks

  • Position-sizing discipline: Conviction WATCH (1 score) — size accordingly; no specific catalyst-fade risk flagged

Bear case

  • Earnings binary: Print-day moves can swing ±15% — gap risk both directions

Sympathy basket (cerebro)

  • TAP via staples r=-0.90 divergent (score 9)
  • UTZ via staples r=-0.90 divergent (score 5)
  • VTEX via tech r=+0.88 sympathetic (score 17)
  • PCOR via tech r=+0.88 sympathetic (score 16)
  • MRVL via semis r=+0.80 sympathetic (score 30)
  • AMD via semis r=+0.80 sympathetic (score 9)

Signals Firing

earningsclinicalauto_macro_adp_payrollsauto_macro_durable_goods
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Pick Track Record

DateListNext-day max runNext-day closeHit +2%?
2026-10-26sec_top_gappers+0.5%+0.2%—
2026-10-26sec_top_moat_emerging+0.5%+0.2%—
2026-10-22sec_top_gappers+0.2%-1.7%—
2026-10-22sec_top_moat_emerging+0.2%-1.7%—
2026-10-19sec_top_gappers+2.5%+2.2%✓ hit
2026-10-19sec_top_moat_emerging+2.5%+2.2%✓ hit
2026-10-14sec_top_gappers+2.3%+1.7%✓ hit
2026-10-14sec_top_moat_emerging+2.3%+1.7%✓ hit
2026-10-13sec_top_gappers+1.7%-0.4%—
2026-10-13sec_top_moat_emerging+1.7%-0.4%—
2026-09-21sec_top_gappers+4.3%+2.9%✓ hit
2026-09-21sec_top_moat_emerging+4.3%+2.9%✓ hit
Lifetime: 10/16 wins · hit-rate 62.5% on +2% intraday

Sympathy Basket

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for BNTX. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Tier 1 setups touched +2% intraday 44.0% of the time across 414 tracked calls. Baseline for everything else: 38.4%. That is a +5.6 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/

  1. Click Become a Founding Member below.
  2. Pay $99 once — not monthly, not ever again.
  3. You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.

30 of 30 founding seats left. The price goes up when they are gone.

Become a Founding Member — $99 once

One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →